185 related articles for article (PubMed ID: 11745233)
21. Usefulness of ¹¹C-methionine positron emission tomography for treatment-decision making in cases of non-enhancing glioma-like brain lesions.
Watanabe A; Muragaki Y; Maruyama T; Shinoda J; Okada Y
J Neurooncol; 2016 Feb; 126(3):577-83. PubMed ID: 26612734
[TBL] [Abstract][Full Text] [Related]
22. Positron emission tomography with ([11C]methyl)-L-methionine, [11C]D-glucose, and [68Ga]EDTA in supratentorial tumors.
Ericson K; Lilja A; Bergström M; Collins VP; Eriksson L; Ehrin E; von Holst H; Lundqvist H; Långsrom B B; Mosskin M
J Comput Assist Tomogr; 1985; 9(4):683-9. PubMed ID: 3926834
[TBL] [Abstract][Full Text] [Related]
23. Amino acid study of cerebral gliomas using positron emission tomography--analysis of (11C-methyl)-L-methionine uptake index.
Mineura K; Sasajima T; Suda Y; Kowada M; Shishido F; Uemura K
Neurol Med Chir (Tokyo); 1990 Dec; 30(13):997-1002. PubMed ID: 1714054
[TBL] [Abstract][Full Text] [Related]
24. Baseline 11C-methionine PET reflects the natural course of grade 2 oligodendrogliomas.
Ribom D; Smits A
Neurol Res; 2005 Jul; 27(5):516-21. PubMed ID: 15978178
[TBL] [Abstract][Full Text] [Related]
25. Positron emission tomography-guided volumetric resection of supratentorial high-grade gliomas: a survival analysis in 66 consecutive patients.
Pirotte BJ; Levivier M; Goldman S; Massager N; Wikler D; Dewitte O; Bruneau M; Rorive S; David P; Brotchi J
Neurosurgery; 2009 Mar; 64(3):471-81; discussion 481. PubMed ID: 19240609
[TBL] [Abstract][Full Text] [Related]
26. [Value of 11C-methionine and PET in the diagnosis of low grade gliomas].
Shishido F; Uemura K; Inugami A; Tomura N; Higano S; Fujita H; Murakami M; Kanno I; Yasui N; Mineura K
Kaku Igaku; 1990 Apr; 27(4):293-302. PubMed ID: 2376915
[TBL] [Abstract][Full Text] [Related]
27. Radiotherapy treatment planning and long-term follow-up with [(11)C]methionine PET in patients with low-grade astrocytoma.
Nuutinen J; Sonninen P; Lehikoinen P; Sutinen E; Valavaara R; Eronen E; Norrgård S; Kulmala J; Teräs M; Minn H
Int J Radiat Oncol Biol Phys; 2000 Aug; 48(1):43-52. PubMed ID: 10924970
[TBL] [Abstract][Full Text] [Related]
28. Dynamic study of supratentorial gliomas with L-methyl-11C-methionine and positron emission tomography.
Lilja A; Bergström K; Hartvig P; Spännare B; Halldin C; Lundqvist H; Långstrom B
AJNR Am J Neuroradiol; 1985; 6(4):505-14. PubMed ID: 2992257
[TBL] [Abstract][Full Text] [Related]
29. [Combined use of positron emission tomography with (18)F-fluorodeoxyglucose and (11)C-methionine for preoperative evaluation of gliomas].
Yamaguchi S; Terasaka S; Kobayashi H; Narita T; Hirata K; Shiga S; Usui R; Tanaka S; Kubota K; Murata J; Asaoka K
No Shinkei Geka; 2010 Jul; 38(7):621-8. PubMed ID: 20628188
[TBL] [Abstract][Full Text] [Related]
30. Prognostic Value of the Metabolic and Volumetric Parameters of
Kim YI; Kim Y; Lee JY; Jang SJ
AJNR Am J Neuroradiol; 2018 Sep; 39(9):1629-1634. PubMed ID: 29954817
[TBL] [Abstract][Full Text] [Related]
31. 18F-fluoro-L-thymidine and 11C-methylmethionine as markers of increased transport and proliferation in brain tumors.
Jacobs AH; Thomas A; Kracht LW; Li H; Dittmar C; Garlip G; Galldiks N; Klein JC; Sobesky J; Hilker R; Vollmar S; Herholz K; Wienhard K; Heiss WD
J Nucl Med; 2005 Dec; 46(12):1948-58. PubMed ID: 16330557
[TBL] [Abstract][Full Text] [Related]
32. The roles of
Kim S; Kim D; Kim SH; Park MA; Chang JH; Yun M
Eur J Nucl Med Mol Imaging; 2018 Jun; 45(6):1012-1020. PubMed ID: 29511838
[TBL] [Abstract][Full Text] [Related]
33. 11C-methionine PET as a prognostic marker in patients with glioma: comparison with 18F-FDG PET.
Kim S; Chung JK; Im SH; Jeong JM; Lee DS; Kim DG; Jung HW; Lee MC
Eur J Nucl Med Mol Imaging; 2005 Jan; 32(1):52-9. PubMed ID: 15309332
[TBL] [Abstract][Full Text] [Related]
34. Direct comparison of 18F-FDG and 11C-methionine PET in suspected recurrence of glioma: sensitivity, inter-observer variability and prognostic value.
Van Laere K; Ceyssens S; Van Calenbergh F; de Groot T; Menten J; Flamen P; Bormans G; Mortelmans L
Eur J Nucl Med Mol Imaging; 2005 Jan; 32(1):39-51. PubMed ID: 15309329
[TBL] [Abstract][Full Text] [Related]
35. Contributions of biological tumor parameters to the incorporation rate of L: -[methyl-(11)C] methionine into astrocytomas and oligodendrogliomas.
Nojiri T; Nariai T; Aoyagi M; Senda M; Ishii K; Ishiwata K; Ohno K
J Neurooncol; 2009 Jun; 93(2):233-41. PubMed ID: 19099197
[TBL] [Abstract][Full Text] [Related]
36. Prognostic Value of O-(2-[18F]-Fluoroethyl)-L-Tyrosine-Positron Emission Tomography Imaging for Histopathologic Characteristics and Progression-Free Survival in Patients with Low-Grade Glioma.
Bette S; Gempt J; Delbridge C; Kirschke JS; Schlegel J; Foerster S; Huber T; Pyka T; Zimmer C; Meyer B; Ringel F
World Neurosurg; 2016 May; 89():230-9. PubMed ID: 26855307
[TBL] [Abstract][Full Text] [Related]
37. Use of 18F-choline and 11C-choline as contrast agents in positron emission tomography imaging-guided stereotactic biopsy sampling of gliomas.
Hara T; Kondo T; Hara T; Kosaka N
J Neurosurg; 2003 Sep; 99(3):474-9. PubMed ID: 12959432
[TBL] [Abstract][Full Text] [Related]
38. Cerebral glioma: evaluation with methionine PET.
Ogawa T; Shishido F; Kanno I; Inugami A; Fujita H; Murakami M; Shimosegawa E; Ito H; Hatazawa J; Okudera T
Radiology; 1993 Jan; 186(1):45-53. PubMed ID: 8380108
[TBL] [Abstract][Full Text] [Related]
39. [Dynamic11C-methionine PET/CT in differential diagnosis of brain gliomas].
Vikhrova NB; Kalaeva DB; Postnov AA; Khokhlova EV; Konakova TA; Batalov AI; Pogosbekyan EL; Pronin IN
Zh Vopr Neirokhir Im N N Burdenko; 2021; 85(3):5-13. PubMed ID: 34156203
[TBL] [Abstract][Full Text] [Related]
40. Dynamic 18F-FET PET in newly diagnosed astrocytic low-grade glioma identifies high-risk patients.
Jansen NL; Suchorska B; Wenter V; Eigenbrod S; Schmid-Tannwald C; Zwergal A; Niyazi M; Drexler M; Bartenstein P; Schnell O; Tonn JC; Thon N; Kreth FW; la Fougère C
J Nucl Med; 2014 Feb; 55(2):198-203. PubMed ID: 24379223
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]